PhD at IDIS, Spain
Dr. Omar Al-Massadi Iglesias is a distinguished biomedical researcher specializing in neuroendocrinology, obesity, and metabolic diseases. With over two decades of experience in academic research, he has made pivotal contributions to the understanding of energy homeostasis, hypothalamic signaling, and obesity-linked complications like type 2 diabetes. Currently serving as a Principal Investigator under the Miguel Servet program at the Instituto de Investigación Sanitaria de Santiago de Compostela, he leads the “Endocrinología Traslacional” group. His career spans multiple high-impact international collaborations and includes over 66 peer-reviewed publications, many in Q1 journals like Nature Communications, Cell Metabolism, and Diabetes. He is also a reviewer for more than 90 scientific journals and has contributed to both academic and clinical translational research. Dr. Al-Massadi’s work has not only advanced science but also impacted public health policies and treatment strategies, making him a highly influential figure in his field.
Professional Profile
Google Scholar | Scopus Profile | ORCID Profile
Education
Dr. Al-Massadi earned a degree in Molecular Biology and Biotechnology from the University of Santiago de Compostela in 2000. He pursued his doctoral studies at the same institution, obtaining a Ph.D. in Physiology in 2010. His doctoral work, which earned him the Extraordinary Doctorate Prize, provided a strong foundation in neuroendocrinology and metabolic regulation. Following this, he enhanced his academic profile through advanced postdoctoral training at top international institutions. Notably, he completed a postdoctoral fellowship at the University of Cincinnati (USA) under the mentorship of Prof. Matthias Tschöp, a globally recognized leader in obesity and diabetes research. He later undertook another postdoctoral position at INSERM-Sorbonne Université in Paris, deepening his expertise in cellular signaling and metabolism. This comprehensive academic journey, combining rigorous theoretical training with international research exposure, has positioned Dr. Al-Massadi as a well-rounded and globally competent scientist.
Experience
Dr. Al-Massadi’s professional experience spans over 20 years in academic and translational research. His career began as a Ph.D. student and early postdoctoral researcher at the University of Santiago de Compostela and the Complejo Hospitalario Universitario de Santiago. He later gained significant international experience in the USA and France, including his pivotal work at the University of Cincinnati and INSERM-Sorbonne Université. Throughout his career, he has participated in 21 competitive research projects, including several as Principal Investigator, and contributed to numerous clinical and preclinical studies. His current role as Principal Investigator in the Miguel Servet program has allowed him to establish his own research group, mentoring graduate students and securing national and regional funding. He has authored over 66 scientific articles, served as a peer reviewer for major journals, and actively contributed to international research networks. His broad experience encompasses molecular biology, endocrinology, neuroscience, and translational medicine.
Research Interest
Dr. Al-Massadi’s primary research interests lie in neuroendocrinology, obesity, and metabolic disease mechanisms. He is particularly focused on understanding the molecular signaling pathways in the hypothalamus that regulate energy homeostasis, appetite, and glucose metabolism. His recent investigations explore the role of Pyk2, a tyrosine kinase, in obesity-induced complications such as type 2 diabetes, aiming to uncover novel therapeutic targets. His translational approach bridges fundamental science with clinical application, particularly in developing innovative treatments for metabolic disorders. He is also interested in mitochondrial dynamics, hormone signaling (e.g., ghrelin and glucagon), and sex-specific metabolic regulation. Through animal models, molecular tools, and human data, Dr. Al-Massadi has made critical contributions to identifying biomarkers and intervention strategies. His passion for interdisciplinary research and commitment to solving real-world health problems make his work both scientifically robust and socially impactful.
Awards and Honors
Dr. Al-Massadi has received numerous accolades recognizing his excellence in scientific research. He was awarded the Extraordinary Doctorate Prize by the University of Santiago de Compostela for his outstanding Ph.D. work. His research contributions have earned him Best Poster and Best Oral Communication awards at national endocrinology and obesity congresses. In 2019, the Spanish Society of Endocrinology and Nutrition honored his work as the Best Published Article of the year. His research has attracted competitive funding through prestigious contracts, including the Miguel Servet, Sara Borrell, and Xunta de Galicia Talent Attraction programs. He has also received international mobility grants and been invited to deliver keynote lectures and scientific talks. In addition, Dr. Al-Massadi holds a European patent (EP24382850.6) for a diagnostic and prognostic method related to obesity. These recognitions highlight not only his scientific talent but also his dedication to translational and impactful biomedical research.
Research Skills
Dr. Al-Massadi possesses an extensive skill set across multiple domains of biomedical research. His core competencies include molecular and cellular biology, animal models of metabolic disease, neuroendocrine regulation, and mitochondrial physiology. He is highly proficient in designing and managing complex experiments involving gene expression analysis, CRISPR/Cas9, immunohistochemistry, and biochemical assays. He has demonstrated expertise in project leadership, securing and managing competitive funding, and supervising doctoral and master’s-level research. His collaborative skills are evidenced by partnerships with global institutions and his active role in multidisciplinary teams. Additionally, he excels in scientific writing, having authored high-impact publications, reviews, and book chapters. As a peer reviewer and scientific committee member, he has evaluated grant proposals and journal articles, showcasing his analytical acumen. His patent development experience reflects innovation, while his communication and mentoring abilities add to his profile as a holistic and forward-thinking researcher.
Publications Top Notes
Title: Central Obestatin and Food Intake Regulation
Authors: CFF Seoane LM, Al-Massadi O, Pazos Y, Pagotto U
Year: 2006
Citation Count: 158
Title: Exercise and Hypothalamic Inflammation
Authors: CX Yi, O Al-Massadi, E Donelan, M Lehti, J Weber, C Ress, C Trivedi, …
Year: 2012
Citation Count: 149
Title: Hypothalamic Ghrelin Pathways and Appetite
Authors: O Al Massadi, M López, M Tschöp, C Diéguez, R Nogueiras
Year: 2017
Citation Count: 148
Title: HDL and Skeletal Muscle Function
Authors: M Lehti, E Donelan, W Abplanalp, O Al-Massadi, KM Habegger, J Weber, …
Year: 2013
Citation Count: 112
Title: MCH and Metabolism Regulation
Authors: M Imbernon, D Beiroa, MJ Vázquez, DA Morgan, C Veyrat–Durebex, …
Year: 2013
Citation Count: 111
Title: Obestatin in Adipocyte Metabolism
Authors: U Gurriarán‐Rodríguez, O Al‐Massadi, A Roca‐Rivada, AB Crujeiras, …
Year: 2011
Citation Count: 103
Title: Ghrelin Acylation and Metabolic Control
Authors: O Al Massadi, MH Tschöp, J Tong
Year: 2011
Citation Count: 96
Title: Ghrelin and Food Reward
Authors: O Al Massadi, R Nogueiras, C Dieguez, JA Girault
Year: 2019
Citation Count: 95
Title: Gastric CB1 Receptor and Ghrelin via mTOR
Authors: LL Senin, O Al-Massadi, C Folgueira, C Castelao, M Pardo, …
Year: 2013
Citation Count: 82
Conclusion
Dr. Omar Al-Massadi Iglesias is an exceptional candidate for the Best Researcher Award, with a track record of excellence in research, innovation, and mentorship. His contributions to the field of obesity and endocrinology are globally recognized, and he has made significant strides in understanding metabolic disorders with clinical implications. His trajectory from international postdoctoral training to becoming an independent research leader, coupled with his prolific publication record and sustained grant success, showcase his future potential as a transformative leader in biomedical research. His work not only advances scientific knowledge but also contributes meaningfully to public health—making him truly deserving of this prestigious recognition.
